https://scholars.lib.ntu.edu.tw/handle/123456789/510019
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Wu, Chi Jung | en_US |
dc.contributor.author | Liu, Wei Lun | en_US |
dc.contributor.author | Lai, Chih Cheng | en_US |
dc.contributor.author | Chao, Chien Ming | en_US |
dc.contributor.author | Ko, Wen Chien | en_US |
dc.contributor.author | Wang, Hsuan Chen | en_US |
dc.contributor.author | Dai, Ching Tzu | en_US |
dc.contributor.author | Hsieh, Ming I. | en_US |
dc.contributor.author | Choi, Pui Ching | en_US |
dc.contributor.author | Yang, Jia Ling | en_US |
dc.contributor.author | YEE-CHUN CHEN | en_US |
dc.date.accessioned | 2020-07-14T08:52:19Z | - |
dc.date.available | 2020-07-14T08:52:19Z | - |
dc.date.issued | 2020-04-01 | - |
dc.identifier.issn | 10806040 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/510019 | - |
dc.description.abstract | © 2020 Centers for Disease Control and Prevention (CDC). All rights reserved. In a multicenter study, we determined a prevalence rate of 4% for azole-resistant Aspergillus fumigatus in Taiwan. Resistance emerged mainly from the environment (TR34/ L98H, TR34/L98H/S297T/F495I, and TR46/Y121F/T289A mutations) but occasionally during azole treatment. A high mortality rate observed for azole-resistant aspergillosis necessitates diagnostic stewardship in healthcare and antifungal stewardship in the environment. | en_US |
dc.language.iso | animation | en_US |
dc.publisher | CENTERS DISEASE CONTROL & PREVENTION | en_US |
dc.relation.ispartof | Emerging Infectious Diseases | en_US |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | cdr1b protein; difenoconazole; fungal protein; high mobility group B1 protein; pyrrole; sterol 14alpha demethylase; tebuconazole; unclassified drug; voriconazole; antifungal agent; fungal protein; pyrrole derivative; antifungal resistance; antifungal susceptibility; Article; aspergillosis; Aspergillus fumigatus; bacterium isolation; cross resistance; fungal colonization; gene mutation; genotype; human; lung aspergillosis; major clinical study; mortality rate; nonhuman; phylogeny; prevalence; Taiwan; antifungal resistance; Aspergillus fumigatus; clinical trial; epidemiology; genetics; microbial sensitivity test; multicenter study; Antifungal Agents; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Taiwan | - |
dc.title | Multicenter study of azole-resistant aspergillus fumigatus clinical isolates, Taiwan | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.3201/eid2604.190840 | - |
dc.identifier.pmid | 32186508 | - |
dc.identifier.scopus | 2-s2.0-85082024122 | - |
dc.identifier.isi | WOS:000524156300031 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85082024122 | - |
dc.relation.pages | 806 | en_US |
dc.relation.journalvolume | 26 | en_US |
dc.relation.journalissue | 4 | en_US |
dc.relation.pageend | 809 | en_US |
item.languageiso639-1 | animation | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
item.openairetype | journal article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Center for Infection Control | - |
crisitem.author.orcid | 0000-0002-1816-9010 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。